Pakistan Tehreek-e-Insaf (PTI) announced a series of protests from Friday
The World Health Organisation (WHO) is currently reviewing Merck’s Covid-19 antiviral oral pill molnupiravir and a recommendation will likely be made by early February, an agency official said on Friday.
Janet Diaz, WHO lead on clinical management, said the WHO’S Guidelines Development Group is also getting ready to review Pfizer’s oral pill.
“We will be looking at that (Pfizer oral pill) data in early February for publication likely at the end of that month.”
Late on Thursday, a WHO panel recommended use of two drugs by Eli Lilly, and GlaxoSmithKline and Vir Biotechnology for Covid-19 patients, adding treatment options as the fast-spreading Omicron variant renders many ineffective.
ALSO READ:
Talking about monoclonal antibody treatments, Diaz said some monoclonals are showing impaired neutralisation against the highly infectious Omicron and may be less effective against it.
However, she said it was not a ‘game changer’ as multiple therapeutic options are currently available for Covid-19.
“We are also monitoring antivirals for development of resistance.”
Pakistan Tehreek-e-Insaf (PTI) announced a series of protests from Friday
By understanding the tactics universities employ, students can strategically craft their applications strategy
Oil demand for road transport should peak around 2025
Some of America's most prestigious universities have been rocked by protests in recent weeks as students and other agitators take over quads
Eight teams will compete in this groundbreaking event and more than 10,000 spectators are expected to witness the inaugural edition
Robust performance acknowledged at its annual general meeting
Israel has baulked at a permanent ceasefire, saying that would only allow Hamas to regroup
Total income reached to Dh5.607 billion compared to Dh4.431 billion, a solid expansion of 26.5 per cent YoY